Sunday, October 28, 2012

Semester Paper-Significance and details of the reaction catalyzed by Acetyl co A carboxylase


 a)  Acetyl co A carboxylase-Fatty acid synthesis starts with the carboxylation of acetyl CoA to malonylCo A catalyzed by Acetyl co A carboxylase . This irreversible reaction is the committed step in fatty acidsynthesis.
 Acetyl CoA carboxylase, contains a biotin prosthetic group. The carboxyl group of biotin is covalently attached to the  epsilon amino group of a lysine residue, as in pyruvate carboxylase and propionyl CoA carboxylase .The enzyme is a multienzyme protein containing a variable number of identical subunits, each containing biotin, biotin carboxylase, biotin carboxyl carrier protein, and transcarboxylase, as well as a regulatory allosteric site.
 The reaction takes place in two steps: (1) carboxylation of biotin involving ATP and (2) transfer of the carboxyl to acetyl-CoA to form malonyl-CoA.
 Regulation of Acetyl co A carboxylase- This enzyme is also the essential regulatory enzyme for fatty acid metabolism.
 a) Hormonal control- The carboxylase is controlled by three global signals glucagon, epinephrine, and insulin that correspond to the overall energy status of the organism. Insulin stimulates fatty acid synthesis by activating the carboxylase, whereas glucagon and epinephrine have the reverse effect.
 b) Allosteric modification-The levels of citrate, palmitoyl Co A, and AMP within a cell also exert control. Citrate, a signal that building blocks and energy are abundant,activates the carboxylase. Palmitoyl CoA and AMP, in contrast, lead to the inhibition of the carboxylase. Citrate facilitates the polymerization of the inactive octamers into active filaments. The level of citrate is high when both acetyl CoA and ATP are abundant.
The stimulatory effect of citrate on the carboxylase is antagonized by palmitoyl CoA, which is abundant when there is an excess of fatty acids. Palmitoyl CoA causes the filaments to disassemble into the inactive octamers.
Palmitoyl CoA also inhibits the translocase that transports citrate from mitochondria to the cytosol, as well as glucose 6-phosphate dehydrogenase, which generates NADPH in the pentose phosphate pathway
 c) Covalent Modification- is carried out by means of reversible phosphorylation and dephosphorylation mediated by hormonal action. AcetylCoA carboxylase is switched off by phosphorylation and activated by dephosphorylation. Epinephrine and glucagon activate protein kinase A to bring about phosphorylation. Hence, these catabolic hormones switch off fattyacid synthesis by keeping the carboxylase in the inactive phosphorylated state.
Insulin stimulates the carboxylase by causing its dephosphorylation by stimulating phosphatase enzyme.
 d)Response to Diet
Fatty acid synthesis and degradation are reciprocally regulated so that both are not simultaneouslyactive. In starvation, the level of free fatty acids rises because hormones such as epinephrine and glucagon stimulate adipose-cell lipase.  In well fed state, Insulin, in contrast, inhibits lipolysis. Acetyl CoA carboxylase also plays a role in the regulation of fatty acid degradation. Malonyl CoA, the product of the carboxylase reaction, is present at a high level when fuel molecules are abundant. Malonyl CoA inhibits carnitine acyl transferaseI, preventing access of fatty acyl CoA s to the mitochondrial matrix in times of plenty.
 e) Long-term control is mediated by changes in the rates of synthesis and degradation of the enzymes participating in fatty acid synthesis.Animals that have fasted and are then fed high-carbohydrate, low-fat diets show marked increases in their amounts of acetyl CoA carboxylase and fatty acid synthase (Another multienzyme complex of fatty acid bio synthetic pathway) within a few days. This type of regulation is known as adaptive control.


------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

HMG Co A Reductase- reaction catalyzed and significance


HMG Co A reductase- 3-hydroxy-3-methylglutaryl CoA reductase (HMG-CoA reductase), is an important control site in cholesterol biosynthesis, this enzyme catalyzes the formation of Mevalonate, the committed step in cholesterol biosynthesis. HMG-CoA reductase is an integral membrane protein in the endoplasmic reticulum and spans the membrane. The active site for this enzyme is found on the cytosolic side of the membrane.
The enzyme catalyzes the irreversible step,
 
Regulation of HMG co A reductase/ cholesterol Biosynthesis- HMG CoA reductase is controlled in multiple ways:
This regulation is mediated primarily by changes in the amount and activity of 3-hydroxy-3-methylglutaryl CoA reductase.
A) Regulation of enzyme activity-
1) Feed back inhibition -HMG-CoA reductase in liver is inhibited by Mevalonate, the immediate product of the pathway, and by cholesterol, the main product. The rate of cholesterol formation is highly responsive to the cellular level of cholesterol.
2) Covalent modification Insulin or thyroid hormone increases HMG-CoA reductase activity, whereas glucagon or glucocorticoids decrease it. Activity is reversibly modified by phosphorylation-dephosphorylation mechanisms, some of which may be cAMP-dependent and therefore immediately responsive to glucagon. Phosphorylation decreases the activity of the reductase.  This enzyme, like acetyl CoA carboxylase(which catalyzes the committed step in fatty acid synthesis, is switched off by an AMP-activated protein kinase. Thus, cholesterol synthesis ceases when the ATP level is low. (Insulin causes dephosphorylation, while glucagon causes phosphorylation).
3) Effect of statins-Becausethe enzyme HMG-CoA reductase is the rate-limiting step of cholesterol biosynthesis,this enzyme is the target for many cholesterol lowering drugs. Statins act by inhibiting HMG-CoA reductase and up-regulating LDL receptor activity. Examples currently in use include atorvastatin, simvastatin, fluvastatin, and pravastatin.
B) Regulation of concentration of HMG Co A reductase- The concentration of HMG Co A Reductase is regulated by three main mechanisms-
i)The rate of synthesis of reductase mRNA(Transcription ) – Transcription of  HMG Co A reductase gene is controlled by the sterol regulatory element binding protein (SREBP).
SREBPs are a family of proteins that regulate the transcription of a range of genes involved in the cellular uptake and metabolism of cholesterol and other lipids. This transcription factor binds to a short DNA sequence called the sterol regulatory element(SRE) on the 5’ side of the reductase gene. In its inactive state, the SREBP is anchored to the endoplasmic reticulum or nuclear membrane. When cholesterol levels fall, the protein is released from its association with the membrane by two specific proteolytic cleavages. The released protein migrates to the nucleus and binds the SRE of the HMG-CoA reductase gene, as well as several other genes in the cholesterol biosynthetic pathway, to enhance transcription.Low concentrations of cholesterol increase the level of mRNA for HMG-CoA reductase, whereas high concentrations of cholesterol decrease the mRNA level.
When cholesterol levels rise, the proteolytic release of the SREBP is blocked, and the SREBP in the nucleus is rapidly degraded. These two events halt the transcription of the genes of the cholesterol biosynthetic pathways. It is feed back regulation.Dietary cholesterol also decreases the endogenous cholesterol synthesis. However, it is only hepatic synthesis that is inhibited by dietary cholesterol. .
ii)The rate of translation of reductase mRNA -is inhibited by non sterol metabolites derived from Mevalonate as well as by dietary cholesterol. Reverse occurs when Mevalonate concentration is low, hence translation is enhanced and amount ofHMG Co A reductase is increased.
iii) The degradation of the reductase is stringently controlled. In response to increasing concentrations of sterols such as cholesterol, the enzyme becomes more susceptible to proteolysis. A combination of these three regulatory devices can regulate the amount of enzyme over a 200-fold range.



------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

Important disorders of Lipid Metabolism


Sr.no.DiseaseBiochemical DefectInheritanceClinical ManifestationsLab. DiagnosisTreatment
1.Refsum diseaseThere is deficiency of phytanic acid oxidase enzyme.Characterized biochemically by the accumulation of phytanic acid in plasma and tissues.Autosomal recessiveThe disease is characterized by night blindness, loss of smell, deafness, muscle weakness and development of dysmorphic features in children.-Serum total cholesterol, HDL and LDL are moderately reduced. -Blood phytanic acid levels are elevated. -Phytanic oxidase activity estimation in skin fibroblast cultures is diagnostic.Eliminate all sources of chlorophyll from diet.Plasmapheresis is needed to remove Phytanic acid from blood.
2.Zellwegar syndromeZellwegar syndrome is characterized by an individual’s inability to beta-oxidize very-long chain fatty acids in the Peroxisomes of the cell, due to a genetic disorder in one of the several genes involved with peroxisome biogenesis.
Zellwegar syndrome is the most severe of the PBDs(Peroxisome biogenesis Syndrome 
Autosomal RecessiveSymptoms at birth may include a lack of muscle tone, an inability to move and glaucoma.
Other symptoms may includeunusual facial characteristics, mental retardation, seizures, and an inability to suck and/or swallow. Jaundice and gastrointestinal bleeding mayalso occur. More than 90% growth failure.

The abnormallyhigh levels of VLCFA ( Very long chain fatty acids ), are most diagnostic.There is no cure for Zellwegar syndrome, nor is there a standard course of treatment. 
Most treatments are symptomatic and supportive.



------------------------------------------ Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

iPhone 5 vs. Galaxy S III



------------------------------------------Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------

iPhone 6 leaked prototype!



------------------------------------------Best Wishes: Dr.Ehab Aboueladab, Tel:01007834123 Email:ehab10f@gmail.com,ehababoueladab@yahoo.com ------------------------------------------